Effect of botulinum toxin treatment in children with cerebral palsy.
Completed
- Registration Number
- NL-OMON21315
- Brief Summary
Arch Phys Med Rehabil. 2006 Dec;87(12):1551-8.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 47
Inclusion Criteria
1. Diagnosis of cerebral palsy (CP), hemiplegia or diplegia, ability to walk with or without a walking aid, with or without an ankle-foot orthosis;
2. gait characterized by persistent flexion of the hip and knee in mid-stance when walking;
Exclusion Criteria
1. BTX treatment in lower extremities 16 weeks before inclusion;
2. Orthopaedic surgery 24 weeks before inclusion;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Gross Motor Function Measure (GMFM);<br /><br>2. Energy cost of walking.
- Secondary Outcome Measures
Name Time Method 1. Spasticity of the treated muscles;<br /><br>2. Passive range of motion of lower extremity joints;<br /><br>3. Edinburgh Visual Gait score (GAIT);<br /><br>4. Pediatric Evaluation Disability Inventory (PEDI), domain ‘mobility’;<br /><br>5. Problem score.